Skip to main content
. 2013 Nov 28;8(11):e80995. doi: 10.1371/journal.pone.0080995

Figure 3. Immunohistochemistry for GVD markers in the Alzheimer's disease hippocampus.

Figure 3

Anti-CHMP2B (A), anti-caspase3 (B), anti-cyclin-dependent kinase 5 (CDK5) (C), anti-casein kinase 1δ (CK1δ) (D), anti-c-jun N-terminal kinase (JNK) (E), anti-leucine-rich repeat kinase 2 (LRRK2) (F), anti-annexin2 (G), anti-flotillin-1 (H), and anti-phosphorylated transactive response DNA binding protein-43 (pTDP43) (I). Arrows indicate granulovacuolar degeneration (GVD) bodies. Scale bars  = 20 µm.